CLINICAL_TRIALS
trial_result
· 2012-01-13
Clinical Trial Update: Pilot Study of APD209 in Cancer Cachexia [Phase 2]
Summary
A Phase 2 pilot study of APD209 for cancer cachexia conducted by Acacia Pharma Ltd has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Acacia Pharma Ltd | Conditions: Cancer-related Cachexia | Phase 2 | Status: COMPLETED